98 related articles for article (PubMed ID: 10816327)
1. Apoptotic and non-apoptotic modes of programmed cell death in MCF-7 human breast carcinoma cells.
Amin F; Bowen ID; Szegedi Z; Mihalik R; Szende B
Cell Biol Int; 2000; 24(4):253-60. PubMed ID: 10816327
[TBL] [Abstract][Full Text] [Related]
2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
3. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
[TBL] [Abstract][Full Text] [Related]
4. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG
Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
7. Death receptor 4 (DR4) efficiently kills breast cancer cells irrespective of their sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Kazhdan I; Marciniak RA
Cancer Gene Ther; 2004 Oct; 11(10):691-8. PubMed ID: 15354201
[TBL] [Abstract][Full Text] [Related]
8. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
Chen T; Wong YS
Int J Biochem Cell Biol; 2009 Mar; 41(3):666-76. PubMed ID: 18718551
[TBL] [Abstract][Full Text] [Related]
9. Normal breast epithelial cells induce apoptosis of MCF-7 breast cancer cells through a p53-mediated pathway.
Toillon RA; Adriaenssens E; Wouters D; Lottin S; Boilly B; Hondermarck H; Bourhis XL
Mol Cell Biol Res Commun; 2000 Jun; 3(6):338-44. PubMed ID: 11032755
[TBL] [Abstract][Full Text] [Related]
10. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
Raffo AJ; Kim AL; Fine RL
Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
[TBL] [Abstract][Full Text] [Related]
11. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells.
Kim H; Chung H; Kim HJ; Lee JY; Oh MY; Kim Y; Kong G
Breast Cancer Res Treat; 2008 Nov; 112(2):287-96. PubMed ID: 18158619
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
14. [A study of the inhibition effect of HIFU and its mechanism of action on the proliferation of human breast cancer cells].
Wang XJ; Yuan SI; Zhang J; Lu YR; Wang YP; Chen XH; Ning QZ; Fu YR; Liu BT; Zeng WF; He YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):60-3. PubMed ID: 14981817
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
Ruiz-Ruiz C; Muñoz-Pinedo C; López-Rivas A
Cancer Res; 2000 Oct; 60(20):5673-80. PubMed ID: 11059759
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
Tobin SW; Brown MK; Douville K; Payne DC; Eastman A; Arrick BA
Cell Growth Differ; 2001 Feb; 12(2):109-17. PubMed ID: 11243465
[TBL] [Abstract][Full Text] [Related]
17. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
[TBL] [Abstract][Full Text] [Related]
18. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
20. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]